English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/150652
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorAbalo, Raquel-
dc.contributor.authorUranga-Ocio, José Antonio-
dc.contributor.authorGirón, Rocío-
dc.contributor.authorVera, Gema-
dc.contributor.authorLópez-Pérez, Ana E.-
dc.contributor.authorMartín, M. Isabel-
dc.date.accessioned2017-05-30T10:38:09Z-
dc.date.available2017-05-30T10:38:09Z-
dc.date.issued2017-
dc.identifierdoi: 10.1111/nmo.12952-
dc.identifiere-issn: 1365-2982-
dc.identifierissn: 1350-1925-
dc.identifier.citationNeurogastroenterology and Motility 29(3): e12952 (2017)-
dc.identifier.urihttp://hdl.handle.net/10261/150652-
dc.description.abstract[Background]: The antineoplastic drug 5-fluoruracil (5-FU) is a pirimidine analog, which frequently induces potentially fatal diarrhea and mucositis. Cannabinoids reduce gastrointestinal motility and secretion and might prevent 5-FU-induced gut adverse effects. Here, we asked whether cannabinoids may prevent diarrhea and mucositis induced by 5-FU in the rat. [Methods]: Male Wistar rats received vehicle or the non-selective cannabinoid agonist WIN 55,212-2 (WIN; 0.5 mg kg injection, 1 injection day, 4 consecutive days) by intraperitoneal (ip) route; on the first 2 days, animals received also saline or 5-FU (150 mg kg injection, cumulative dose of 300 mg kg). Gastrointestinal motor function was radiographically studied after barium contrast intragastric administration on experimental days 1 and 4. Structural alterations of the stomach, small intestine and colon were histologically studied on day 4. PAS staining and immunohistochemistry for Ki67, chromogranin A and CD163 were used to detect secretory, proliferating, and endocrine cells, and activated macrophages respectively. [Key Results]: As shown radiographically, 5-FU induced significant gastric emptying delay (on days 1 and 4) and diarrhea (on day 4). WIN did not significantly alter the motility curves obtained for either control or 5-FU-treated animals but tended to reduce the severity of 5-FU-induced diarrhea and increased permanence of barium from day 1 to the beginning of day 4 in 5-FU-treated animals. 5-FU-induced mucositis was severe and not counteracted by WIN. [Conclusions and Inferences]: 5-FU-induced diarrhea, but not mucositis, was partly prevented by WIN at a low dose. Cannabinoids might be useful to prevent chemotherapy-induced diarrhea.-
dc.description.sponsorshipThis work was supported by Ministerio de Educación y Ciencia (SAF201-40075-C02-01) and Comunidad de Madrid (S2010/BMD-2308).-
dc.publisherJohn Wiley & Sons-
dc.relationS2010/BMD-2308/CANNAB-
dc.rightsclosedAccess-
dc.subject5-fluorouracil-
dc.subjectDiarrhea-
dc.subjectGastrointestinal motility-
dc.subjectChemotherapy-induced adverse effects-
dc.subjectCannabinoids-
dc.titleMay cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat-
dc.typeartículo-
dc.identifier.doi10.1111/nmo.12952-
dc.date.updated2017-05-30T10:38:10Z-
dc.description.versionPeer Reviewed-
dc.language.rfc3066eng-
dc.contributor.funderComunidad de Madrid-
dc.contributor.funderMinisterio de Educación y Ciencia (España)-
dc.relation.csic-
dc.identifier.funderhttp://dx.doi.org/10.13039/100012818es_ES
Appears in Collections:(CIAL) Artículos
(IQM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.